Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Abbott Sues India’s Lupin Over Cholesterol Generic

This article was originally published in PharmAsia News

Executive Summary

U.S.-based Abbott Laboratories has filed a suit to stop India's Lupin from selling a generic of Abbott's cholesterol drug Niaspan (niacin). Abbott said in its suit it has seven U.S. patents on the drug, the earliest not set to expire until 2013. The American company, which acquired the drug when it bought Kos Pharmaceuticals in 2006, filed the patent suit in two separate federal courts. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts